Dr. Mehta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 412-692-4834- Is this information wrong?
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
- UPMC Medical EducationFellowship, Hospice and Palliative Medicine, 2009 - 2010
- Mercy Catholic Medical CenterResidency, Internal Medicine, 2006 - 2009
- Government Medical College PatialaClass of 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- WA State Medical License 2022 - 2025
- TX State Medical License 2016 - 2024
- OK State Medical License 2020 - 2021
- MN State Medical License 2015 - 2017
- PA State Medical License 2006 - 2014
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant Start of enrollment: 2021 Apr 08
Publications & Presentations
PubMed
- Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.Sairah Ahmed, Qaiser Bashir, Roland L Bassett Jr, Fauzia Ullah, Fleur Aung, Benigno C Valdez, Amin M Alousi, Chitra Hosing, Partow Kebriaei, Issa Khouri, David Marin, ...> ;American Journal of Hematology. 2024 Apr 1
- Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective.Xinyi Fan, Ailie Armstrong, Masumi Ueda Oshima, Karen L Syrjala, Rachel B Salit, Stephanie J Lee, Neel S Bhatt, Paul A Carpenter, Laura Connelly-Smith, Elizabeth Krako...> ;Transplantation and Cellular Therapy. 2024 Mar 30
- Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes.Rohtesh S Mehta, Effie W Petersdorf, Stephen R Spellman, Stephanie J Lee> ;Blood Advances. 2024 Mar 11
- Join now to see all
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
Abstracts/Posters
- Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS PatientsRohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Guest Editorial: Advances in Immunotherapy for Hematological MalignanciesFebruary 9th, 2018
Professional Memberships
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
- Fred Hutchinson Cancer CenterSeattle, Washington
- M Health Fairview Southdale HospitalMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: